Caina Technology Co

Caina Technology Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of Caina Technology Co (301122.SZ) as of Nov 14, 2026 is 15.20. In the previous year, Cash Conversion Cycle (CCC) was 11.43 — a change of 32.99% (higher).

Cash Conversion Cycle

15.20

YoY

32.99%

Last updated:

Cash Conversion Cycle (CCC) of Caina Technology Co is 2025 15.20 . Cash Conversion Cycle (CCC) of Caina Technology Co was 2024 11.43 . It decreases by 32.99% higher compared to the previous year.

The Caina Technology Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
60.42 CNY
Jan 1, 2019
86.32 CNY
Jan 1, 2020
35.39 CNY
Jan 1, 2021
56.88 CNY
Jan 1, 2022
36.92 CNY
Jan 1, 2023
88.49 CNY
Jan 1, 2024
11.43 CNY
Jan 1, 2025
15.20 CNY
The Caina Technology Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
15.20+32.99%
11.43-87.08%
88.49+139.66%
36.92-35.08%
56.88+60.71%
35.39-59.00%
86.32+42.86%
60.42-225.87%
-48.01—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Caina Technology Co Stock analysis

What does Caina Technology Co do? Caina Technology Co., Ltd. manufactures medical consumables including puncture needles, syringes, laboratory consumables, and masks. The company's main products are reusable copper base injection needles, aluminum base injection needles, disposable aluminum-plastic inlaid injection needles, safety blood collection needles, sheathed syringes, disposable Sterile syringes, petri dishes, and reagent tubes. Caina Technology exports its products to the United States, the United Kingdom, and the European Union, serving international markets with its medical supplies. The company generates revenue through the sale of its medical consumables to global healthcare providers and distributors. Its product range targets hospitals, clinics, and laboratories requiring reliable medical equipment. Caina Technology's focus on exporting to developed markets ensures steady demand for its high-quality, compliant medical products. Caina Technology's business model relies on manufacturing and exporting medical consumables to international customers. The firm's product portfolio includes specialized items like safety blood collection needles and sterile syringes, which are essential for healthcare facilities. By targeting key regions such as the United States, United Kingdom, and European Union, the company secures consistent sales channels for its medical supplies. Caina Technology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Caina Technology Co stock

Cash Conversion Cycle (CCC) of Caina Technology Co is 15.20 in 2025.

Cash Conversion Cycle (CCC) of Caina Technology Co changed from 11.43 to 15.20, representing a 32.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) Caina Technology Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s Caina Technology Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Caina Technology Co

All Key Metrics — Caina Technology Co